Waldenström Macroglobulinemia
- 1 October 2014
- journal article
- review article
- Published by Elsevier BV in Hematology/Oncology Clinics of North America
- Vol. 28 (5), 945-970
- https://doi.org/10.1016/j.hoc.2014.06.003
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Helical assembly in the MyD88–IRAK4–IRAK2 complex in TLR/IL-1R signallingNature, 2010
- Site-specific Phosphorylation of CXCR4 Is Dynamically Regulated by Multiple Kinases and Results in Differential Modulation of CXCR4 SignalingOnline Journal of Public Health Informatics, 2010
- Identification of Critical Residues of the MyD88 Death Domain Involved in the Recruitment of Downstream KinasesOnline Journal of Public Health Informatics, 2009
- Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemiaBlood, 2009
- Identification of Copy Number Abnormalities and Inactivating Mutations in Two Negative Regulators of Nuclear Factor-κB Signaling Pathways in Waldenström's MacroglobulinemiaCancer Research, 2009
- Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia patients: a population-based study in SwedenBlood, 2008
- Targeting NF-κB in Waldenstrom macroglobulinemiaBlood, 2008
- The Akt pathway regulates survival and homing in Waldenstrom macroglobulinemiaBlood, 2007
- Regulation of CXCR4 signalingBiochimica et Biophysica Acta (BBA) - Biomembranes, 2007
- Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's MacroglobulinemiaSeminars in Oncology, 2003